Ford, Volkswagen Ink Major Joint Project Agreement, Includes New Electric Vehicle
AstraZeneca wins fresh U.S. funding in race for COVID-19 treatment
When times got tough, the biopharma industry hit the Zoom button and kept things moving at a multibillion-dollar clip
Airbus Gets No New Aircraft Orders In May Amid Aviation Crisis
Norwegian Cruise Line: There Is Light at the COVID Tunnel, Says 5-Star Analyst
Moderna's (MRNA) Stock Will Surge 80% From Current Levels, Says Analyst
Alibaba Rolls Out Online Business Services As Covid-19 Boosts Digitalization Need
Gilead’s next step on coronavirus
U.S. awards new contract for potential COVID-19 vaccine
Cyclical ETFs rebound as global economy reopens
Portfolio positioning for a recovery scenario
Top 10 fastest growing and declining retail brands in the world
Six Flags Set to Partially Reopen in June, Stock Jumps on News
Light at the End of the Tunnel Still Not Bright Enough for Royal Caribbean, Says Analyst
Researchers define exactly what they saw in the first positive remdesivir study for Covid-19. But what's that worth to Gilead?
Immunity Passports May Be Blockchain's Killer-App, Says Overstock CEO
Airway Therapeutics, Celonic Group partner to produce AT-100 as candidate for coronavirus
Clorox Bumps Up Dividend By 5%; Shares Rise In Pre-Market
Pfizer Seeks To Raise $4 Billion From Debt Sale
Billionaire Ray Dalio Snatches up These 3 “Strong Buy” Stocks
Uber/Grubhub: Pandemic Profiteering, Merger Moratoriums, and Rising Concentration … Or Not
Uber Said to Be in Talks to Snap Up Rival GrubHub
The Retail Earnings Parade Begins this Week
There is no magic bullet
As Bitcoin Tests $10K, Experts Answer: ‘Where to From Here?’